We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Detects Congestive Heart Failure from Single Heartbeat

By HospiMedica International staff writers
Posted on 30 Sep 2019
A new study reports successful identification of severe chronic heart failure (CHF) in 100% of cases using a single heartbeat recording from an electrocardiogram (ECG).

Researchers at the University of Surrey (Guildford, United Kingdom), the University of Warwick (Coventry, United Kingdom), and The Organizational Neuroscience Laboratory (OneLab; London, United Kingdom) developed the novel approach, which is based on artificial intelligence (AI). More...
The technique uses a convolutional neural network (CNN) data tree to detect data patterns and structures at extremely high efficiency, which accurately identifies CHF on the basis of one raw ECG heartbeat.

The CNN allows time series sub-sequences that serve as the input data to be visualized, thus allowing it to discriminate between CHF and healthy subjects, which not only allows faster detection, but also helps to understand how certain tissue behavior is related to the signals recorded. The researchers tested the model on ECG datasets comprising 490,505 heartbeats; it achieved 100% CHF detection accuracy, and also identified class-discriminative heartbeat sequences and specific ECG morphological characteristics. The study was published on September 3, 2019, in Biomedical Signal Processing and Control Journal.

“We trained and tested the CNN model on large publicly available ECG datasets featuring subjects with CHF as well as healthy, non-arrhythmic hearts. Our model delivered 100% accuracy; by checking just one heartbeat we are able detect whether or not a person has heart failure,” said study author Sebastiano Massaro, PhD, of University of Surrey. “Our model is also one of the first known to be able to identify the ECG' s morphological features specifically associated to the severity of the condition.”

“We envision the adaptation of this system to wearable devices that may be able to perform prediction and detection of CHF using interim ECG recordings, by looking at individual heartbeat morphology. This could allow not only cardiologists but even patients and their caregivers, nurses, trainees, and GPs to take part in the detection process,” concluded Dr. Massaro. “With the completion of the training phase, the network works very rapidly, making it fit for deployment into cloud systems or adaptation to mobile devices.”

CHF is a progressive pathophysiological condition responsible for chronic loss of pumping power in the heart. According to the European Society of Cardiology (ESC), around 26 million people worldwide are affected. Its prevalence increases quickly with age, and mortality rate is closely associated with the degree of severity, reaching peaks of 40% in the most serious events. CHF is also one of the foremost reasons for hospitalization in the elderly, and it is characterized by a resilient relapse rate, with half of the outpatients readmitted within a few months from hospital discharge.

Related Links:
University of Surrey
University of Warwick
The Organizational Neuroscience Laboratory


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
MR Trolley
MR9002
New
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.